MedTrace Logo

Healthy Aging Through Functional Food

NCT02095873 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-03-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether dietary inducers of glyoxalase 1 are effective in improving metabolic and vascular health.

Conditions

  • Glucose Intolerance
  • Aortic Stiffness
  • Vasodilation

Interventions

DIETARY_SUPPLEMENT

Glyoxalase 1 (Glo1) inducer

Dietary bioactive

DIETARY_SUPPLEMENT

Placebo

Mannitol, 108 mg

Sponsors & Collaborators

  • Technology Strategy Board, United Kingdom

    collaborator OTHER

  • Unilever R&D

    collaborator INDUSTRY

  • University of Warwick

    lead OTHER

Principal Investigators

  • Paul J Thornalley, BSc PhD · University of Warwick

  • Martin O Weickert, MD · University Hospitals Coventry & Warwickshire NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-02-28
Completion
2015-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02095873 on ClinicalTrials.gov